NVRVF yields 2000.00% · PFE yields 6.13%● Live data
📍 NVRVF pulled ahead of the other in Year 1
Combined, NVRVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NVRVF + PFE for your $10,000?
Novra Technologies Inc., together with its subsidiaries, provides hardware, software, and services for the distribution of satellite data in Canada, North America, Central America, South America, Europe, the Middle East, Africa, East Asia, South Asia, Southeast Asia, and Oceania. The company offers video distribution products and systems for the provision of end-to-end solutions to traditional and non-traditional video networks; infrastructure solutions for broadcast radio networks, including uplink and receive site equipment, as well as network management, encryption, and targeted regionalization/ad insertion options; and data distribution for hardware infrastructure, as well as content distribution network software solution. It also provides digital cinema network infrastructure and services; appliances for cinemas; decoders for live events; alternative content in 2D and 3D; digital cinema distribution software solutions; and DVB and ATSC compliant receivers for the broadband communications network market. The company was founded in 2000 and is headquartered in Winnipeg, Canada.
Full NVRVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.